Shimadzu’s Nexera XS inert is designed to prevent both adsorption of target molecules to metal surfaces and mobile-phase corrosion.
Shimadzu’s Nexera XS inert is a bioinert and biocompatible ultra-high performance liquid chromatography that is designed to prevent the adsorption of target molecules to metal surfaces and mobile-phase corrosion caused by high salt content and extreme pH conditions.
The system utilizes a metalfree sample flow path, which prevents unwanted interaction with biopolymers that are prone to adsorption onto exposed metal sites, resulting in reduced sample loss and excellent peak shape in data results. Additionally, all wetted surfaces of the system use corrosionresistant materials, which are designed to promote stability against mobile-phase solvents that contain high concentrations of salts or acids. This makes it well-suited for analyzing biopharmaceutical molecules, such as antibodies, peptides, and nucleic acid drugs.
The system uses a stainless-steel-casing-reinforced polyether ether ketone tubing to promote mechanical and chemical resistance. It is designed for a pressure tolerance of >100 MPa while maintaining a bioinert flow path. An optional pHM-40 offers realtime measurement of the mobile-phase pH during an experiment.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.